Psoriatic Arthritis

Top Story

Apremilast effective among biological-naive patients with PsA

February 15, 2018
In the Journals

Patients with PsA, psoriasis undertreated for CVD risk factors

February 14, 2018
A large number of patients with psoriatic arthritis and psoriasis are underdiagnosed and go without necessary treatment for hypertension and dyslipidemia, according to…
In the Journals

Psoriatic arthritis rates increasing in Taiwan despite psoriasis plateau

February 6, 2018
Prevalence and incidence rates of psoriatic arthritis increased significantly in Taiwan from 2000 to 2013, while psoriasis exhibited no substantial change in incidence…
In the Journals

RAPID3 index fails to assess mental health for psoriatic disease

February 2, 2018
The Routine Assessment of Patient Index Data 3 for rheumatoid arthritis cannot be used in patients with psoriasis and psoriatic arthritis as it fails to account for…
More Headlines »
CME

The Role of the Inflammatory Cascade in the Pathogenesis and Treatment of Psoriatic Arthritis: New and Emerging Therapies

This activity is supported by educational grants from Celgene Corporation and Novartis Pharmaceuticals Corporation.

The workings of the inflammatory cascade are not fully defined, but recent findings have demonstrated roles for novel…
More »
Video
Meeting News

VIDEO: Mease discusses effectiveness of tofacitinib against PsA

December 2, 2016
More »
Resource Centers
American College of Rheumatology Annual Meeting

American College of Rheumatology Annual Meeting

CME ABIM MOC

Ace the Case: A 29-year-old Woman with Psoriasis Vulgaris

There is no commercial support for this activity.

This “Ace the Case” study will discuss the assessment and treatment of a 29-year-old woman with Psoriasis Vulgaris…
More »